in 32 (82 percent) of the patients (group A) for a
median of 63 hours and a median peak infusion rate of 67 mcg/kg/min. Other
agents, such as midazolam and pentobarbital, were used in the other seven
(18 percent) patients (group B). Within group A, three patients had sudden
unexplained cardiac arrest while on propofol infusions, resulting in two
deaths, while no deaths occurred in group B. Median hospital stay (12 days)
and ICU length of stay (9 days) did not differ between the two groups. The
overall occurrence of PRIS was 30 percent of patients in group A (seven
patients with bradycardia, three patients with sudden unexplained cardiac
arrest) compared with less than 3 percent (one patient with bradycardia) in
group B.
In light of the new data, Dr. Iyer advises that caution should be taken
with the use of propofol to treat patients with RSE. "There are several
other medications we can turn to in the case of uncontrolled seizures," he
said. "Alternative agents should first be tried for patients with RSE, and
propofol should only be used after exhausting all other options."
"With increasing awareness of the risks of propofol, physicians may
become more cautious about using propofol for prolonged periods and at high
doses," said James A. L. Mathers, Jr., MD, FCCP, President of the American
College of Chest Physicians.
CHEST 2008 is the 74th annual international scientific assembly of the
American College of Chest Physicians, held October 25-30 in Philadelphia,
PA. ACCP represents 17,000 members who provide patient care in the areas of
pulmonary, critical care, and sleep medicine in the United States and
throughout the world. The ACCP's mission is to promote the prevention and
treatment of diseases of the chest through leadership, education, research,
and communication. For more information about the ACCP, please visit the
ACCP Web site at http://www.chestnet.org.
'/>"/>SOURCE American College of Chest Physicians Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
Study provides hope that some transplant patients could live free of antirejection drugs2.
Study provides hope that some transplant patients could live free of anti-rejection drugs3.
HIV denialists spread misinformation online -- consequences could be deadly; and more4.
Virus Could Help Drive Obesity5.
Discovery of sugar sensor in intestine could benefit diabetes6.
Cranberry Could Juice Up Ovarian Cancer Treatment7.
Treating Diabetes During Pregnancy Could Lead to Thinner Kids8.
High-risk behaviors could lead to HIV epidemic in Afghanistan9.
Chinas 1-child policy could backfire on its elderly10.
1.5 million children could be saved11.
FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use